BerandaDNA • BMV
add
Ginkgo Bioworks Holdings Inc
Tutup sebelumnya
$262,00
Rentang tahun
$164,00 - $770,40
Kapitalisasi pasar
433,15Â jt USD
Rasio P/E
-
Hasil dividen
-
Bursa utama
NYSE
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 48,32Â jt | 27,34% |
Biaya operasional | 124,26Â jt | -39,90% |
Laba bersih | -90,96Â jt | 45,18% |
Margin laba bersih | -188,25 | 56,95% |
Penghasilan per saham | — | — |
EBITDA | -72,62Â jt | 56,02% |
Tarif pajak efektif | -0,10% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 516,92Â jt | -38,49% |
Total aset | 1,29Â M | -18,23% |
Total liabilitas | 646,04Â jt | 8,67% |
Total ekuitas | 647,43 jt | — |
Saham yang beredar | 55,53 jt | — |
Harga terhadap nilai buku | 22,47 | — |
Tingkat pengembalian aset | -16,47% | — |
Tingkat pengembalian modal | -19,42% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -90,96Â jt | 45,18% |
Kas dari operasi | -51,52Â jt | 42,28% |
Kas dari investasi | -198,68Â jt | -1.540,66% |
Kas dari pembiayaan | -207,00Â rb | 75,50% |
Perubahan kas bersih | -250,34Â jt | -144,54% |
Arus kas bebas | -16,32Â jt | 62,99% |
Tentang
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
CEO
Didirikan
2008
Kantor pusat
Situs
Karyawan
834
